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Particulate matter air pollution (PM) has been related to cardiovascular disease mortality in a
numberofrecent studies. lThepathophysiologic mechanisms forthis association are under study.
Lowheart ratevariability, a marker ofpoorcardiac autonomic control, is associated with higher
risk ofmyocardial infarction and sudden cardiac death. To address the possible mechanisms for
PM-cardiovaclar dise mortality, we examined thecardiac autonomicresponse to dailyvara-
tions in PM in 26 elderly (mean age 81) individuals for 3 consecutive weeks. Several standard-
ized methods were used to measure 24-hr average PM concentrations prior to the dinical test
inside (indoor PM2.5) and immediately outside (outdoor PM25 and PM2%1o) ofparticipants'
residences. Resting, supine, 6-min R wave to R wave (R-R) interval data were collected to esti-
mate high frequency (0.154.40 Hz) and low frequency (0.04-0.15 Hz) powers and sdard
deviation of normal R-R intervals (SDNN) as cardiac autonomic control indices. Participant-
specific lower heart rate variability days were defined as days for which the high-frequency
indices fell below the first tertle ofthe individual's high-frequency distribution over the study
period. Indoor PM25 > 15 pg/m3 was used to define high pollution days. Results show that the
odds ratio (95% confidence interval) oflowheartrate variabilityhighfrequencyforhigh (vs. not
high) pollution days was 3.08 (1.43, 6.59). The 3-coeffidents (standard error) from mixed mod-
els to asse the quantitative relationship between variations in indoor PM25 and the log-tras-
formed high frequency, low frequency, and SDNN were: -0.029 (0.010), -0.027 (0.009), and
-0.004 (0.003), respectively. This firststudyofcardiac autonomic control response to dailyvari-
ations ofPM25 indicates that increasd levels ofPM2.5 are associated with lower cardiac auto-
nomic control, suggesting a possible mechanistic link between PM and cardiovascular dse
mortality. Key words. ambient air pollution, autonomic system, cardiovascular dises, elderly,
heart rate variability, particulate matter, PM25. Environ Health Perspet 107:521-525 (1999).
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Many epidemiologic studies have shown an
association between exposure to particulate
air pollution below the current national air
quality standard and excess mortality from
cardiopulmonary diseases (1).
Consistent with the mortality findings,
epidemiologic studies in the United States
(2-4), Canada (5,6), and Europe (7-9) also
demonstrate significant associations of
ambient air pollutants with hospital admis-
sions for respiratory and cardiovascular dis-
eases. However, the observed excess mortali-
ty and morbidity associated with relatively
low particulate matter (PM; the subscript
number denotes the particle size in microm-
eters) levels have been questioned because of
an apparent lack ofany biologically demon-
strable mechanisms. A direct link between a
pathophysiologic effect on the heart and
mortality or morbidity in human popula-
tions has not yet been established. The role
of air pollution in cardiovascular disease is
a recent focus of attention. Several investi-
gators reported an association between par-
ticle air pollution and hospital admissions
for ischemic heart disease, congestive heart
failure, or dysrhythmias (10-13). Watkinson
et al. (14) produced arrhythmias after
installation ofcombustion particles into rat
lungs, resulting in a doubling of mortality
rate, and Godleski et al. (15) observed elec-
trocardiographic changes including T-wave
alternans and arrythymias in dogs exposed
to concentrated ambient air particles. The
link between inhalation of particle air pol-
lution and effects on cardiac rhythm may
be the induction of an inflammatory
response in the lung with a subsequent
release ofchemical mediators that alter the
autonomic nervous system control of car-
diac rhythm (16).
The research question for this study is:
What is the physiologic link between air
pollution exposure and cardiopulmonary
effects in susceptible populations?
Specifically, this study is designed to inves-
tigate whether the changes in the concen-
trations ofparticulate matter are associated
with the changes in the cardiac autonomic
control (CAC), as measured by the analysis
of heart rate variability (HRV), in a group
ofelderly individuals.
Population and Methods
Population. This study was designed as a
short-term (21 days) longitudinal monitor-
ing of daily changes in both particulate
matter concentrations and in cardiac auto-
nomic activity. Study participants were
selected from a retirement center in metro-
politan Baltimore, Maryland.
As described by Creason et al. (17), the fol-
lowing exclusion criteriawere used to screen for
eligible participants: uncontrolled hypertension
(systolic blood pressure > 190 ordiastolic blood
pressure . 100 mm Hg), angina pectoris
and/or heart attack in past 12 months, physi-
cian-diagnosed episodes of syncope, heart fail-
ure, current smoker, retinal disease, diabetes,
dementia, dialysis treatment, acute illness (> 2
days) within the past week, need for supple-
mental oxygen, or having a pacemaker. After
the eligibility screening and after attending
small group meetings with trained recruiters,
26 ofthe 58 eligible individuals volunteered to
participate in this study. These 26 participants
were then individually informed about study
content, risks and discomforts, procedure for
confidentiality, right of withdrawal, daily
scheduling requirements, and study incentives
and benefits. Signed consent forms were then
obtained.
Particulate matterpollution assessment.
The following measures of particulate con-
centrations were obtained during the study
period (18,19):
* Integrated 24-hr indoor mass concentra-
tions ofPM2.5 were obtained in the hall-
way of the retirement facility near the
rooms where physiologic testing of partic-
ipants was administered. The results from
this monitor were labeled "hallway."
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* Continuous indoor PM2.5 concentrations
were obtained with a tapered element
oscillating microbalance (TEOM) instru-
ment located in the hallway beside the
stationary hallway PM monitor. The
TEOM monitor was used with a PM2.5
cyclone inlet and provided hourly mea-
sures of fine particle concentrations.
Because the instrument monitored fine
particles continuously, two metrics were
derived from the output of this monitor.
The first was a 24-hr averagePM2.5, aver-
aged to the time when each subject began
his or her daily battery of physiologic
testing. This metric was labeled "indoor~
24 hr" to represent the average 24-hr
concentration just prior to each person's
actual start of testing. The other metric
was a 24-hr average as of 7 A.M. of the
date of each day's physiologic testing.
This metric was labeled "indoor-7 AM."
* Integrated 24-hr outdoor concentrations
of PM2.5 and PM2.5-10 (fine and coarse
particulate matter) were obtained with a
dichotomous monitor placed on the out-
door parking deck of the retirement cen-
ter. Samples were collected on Teflon (E.I.
Du Pont de Nemours and Company,
Wilmington, DE) filters, and sampler flow
rates were 15 L/min for the PM2.5 fine
fraction and 1.67 L/min for the PM2 -0
coarse fraction. Data from this monitor
were labeled "outdoor."
Cardiac autonomic activity. Analysis of
beat-to-beat HRV was used to assess cardiac
autonomic control for all participants daily
over the entire study period. For the mea-
surement of HRV, three electrocardiogram
(ECG) electrodes were positioned on the
subject. Two electrodes were in the regular
ECG Vi and V6 locations on the epigastri-
um and one was on the lower right extremi-
ty. Resting supine 6-min beat-to-beat heart
rate data were collected after participants
remained comfortably in the supine position
for 10 min. A dedicated computer and spe-
cialized software (PREDICT II HRVECG,
Arrhythmia Research Technology, Inc.,
Austin, TX) were used for continuous
detecting and recording of ECG R waves.
The system uses a wave form correlation
technique to correlate each digitized possible
electrocardiographic wave complex (QRS)
with a participant-specific QRS template
with the overall correlation coefficient preset
to 0.75. The participant-specific QRS tem-
plate was identified as a normal QRS tem-
plate by trained and certified technicians
through visual inspection of several QRSs.
The sampling frequency was set to 1000 Hz,
as recommended by the manufacturer. Each
of the possible QRSs was marked as a nor-
mal QRS if the wave form correlation coef-
ficient was > 0.75; otherwise they were
marked as artifact QRS. The system then
calculated beat-to-beat R wave to R wave
(R-R) intervals for the entire 6-min period.
The R-R interval data were processed in
a central location by one trained computer
programmer. During the data-processing
phase, a data cleaning program was used to
remove any R-R intervals having an artifact
QRS from the HRV analysis. Segments
with such artifacts were imputed and R-R
intervals in these segments were recalcu-
lated using an algorithm developed by
Arrhythmia Research Technology, Inc. Fast
Fourier transformation was performed to
estimate the power spectral density (PSD).
An example ofthe PSD curve with the cor-
responding time-domain beat-to-beat R-R
interval histogram inserted is shown in
Figure 1 for one participant. From the PSD
curve, the high frequency spectral power
component (HF) and the low frequency
spectral power component (LF), defined as
the power (area) between 0.15 and 0.40 Hz
and between 0.04 and 0.15 Hz bands under
the PSD curve, respectively, were calculated.
The standard deviation of all normal R-R
intervals (SDNN) was calculated from the
time-domain data after the replacement of
artifacts. The average heart rate from the
6-min R-R interval data was also calculated.
In this study, any record with 15% or
more of QRS artifacts in all possible QRS
complexes was excluded from analysis, even
though these segments could be successful-
ly imputed, as the manufacturer suggested.
These exclusion criteria were implemented
to reduce the influence of data imputation
on the estimates ofHRV.
Other covariables. Other covariables,
such as age, ethnicity, sex, and health sta-
tus, were obtained using a standardized
questionnaire. A participant was classified
as having previous cardiovascular related
conditions (labeled as the compromised
group) if the medical record review and/or
medication survey revealed active treatment
of any of the following conditions: hyper-
tension, coronary heart disease, episodes of
arrhythmia, and thyroid abnormalities
requiring thyroid medication.
Statistical methods. Random coefficient
regression models were used in the analysis
of the study data (20). Most models con-
tamned fixed effects ofintercept, age, sex, car-
diovascular health status, andPM2.5 particu-
late level as measured by various exposure
monitors, with age and PM2.5 being contin-
uous variables. Models with separate slopes
for each ofthe health status groups were also
fit. In addition to the population-fixed
effects, each subject was allowed to have an
individual incremental slope and intercept
for PM. Using model-fitting information
available in the SAS Mixed Model (20) out-
put for each model, it was determined that
intercepts for each subject were necessary,
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Figure 1. An example of a power spectral density curve following fast Fourier transformation, derived
from time-domain heart rate data (inserted panel). Very low-frequency power (0.00-0.04 Hz) 71.8 msec2;
low-frequency power (0.04-0.15 Hz) 1,360 msec2; high-frequency power (0.15-0.40 Hz), 575 msec2; total
power, 2,010 msec2; standard deviation of all normal RR intervals, 82.6 msec.
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was determined through selection of the
appropriate error structure based on the
model-fitting criteria as described above.
Other statistical summaries and analy-
ses were included as appropriate in specific
cases. For example, in analyzing the HRV
data, a logistic model assessing normal and
low HRV versus high and low PM2.5 par-
ticulate levels was used.
Results
The reexamination rates were high, and
only a few subjects failed to complete the
entire 3-week study period. The greatest
loss of data was attributable to the lack of
functioning air monitors on some of the
Table1. Characteristics (mean ±standard deviation, proportion, orrange) ofstudyparticipants.
Without With
All subjects cardiovascular cardiovascular
Characteristic combined (n = 26) conditions (n = 8) conditions (n = 18)
Number of subjects 26 8 18
Age
Mean (years) 81 78 82
Range (years) 65-89 65-84 69-89
Sex %female) 73 63 78
Race(% whites) 96 88 100
History of hypertension (%) 42 0 61
Heart rate variability
Log 10 high freq power(msec2) 2.61 ±0.38 2.40 ± 0.31 2.70 ± 0.37
Log 10 lowfreq power(msec2) 2.71 ± 0.32 2.61 ± 0.15 2.76 ± 0.36
Log 10 SDNN (msec) 1.74± 0.15 1.67 ± 0.09 1.77 ±0.16
Heart rate (5-min mean, beat/min) 73 ± 7.8 74 ± 5.8 72 ±8.6
Seated blood pressure (mm Hg)
Systolic 132 ±16 124±11 135 ±17
Diastolic 78 ±8 75 ±7 79±9
SDNN, standard deviation of all normal R-wave to R-wave intervals.
Table 2. Adjusted 1-coefficients and 95% confidence intervals from mixed model analysis of the associa-
tions between the levels of particulate matter and cardiac autonomic control, as measured by heart rate
variability.
Without cardiovascular With cardiovascular All subjects
Variable Exposuremetric conditions (n =8)a conditions (n =18)a combined(n =26)b
High-frequency Hallway -0.015 -0.027* -0.024*
power (log10)C (-0.043, 0.013) (-0.045, -0.010) (-0.038, -0.009)
Indoor, 24-hr 0.006 -0.028* -0.019
(-0.035, 0.046) (-0.052, -0.005) (-0.040, 0.001)
Indoor, 7A.M. 0.005 -0.031 * -0.022*
(-0.036, 0.045) (-0.055, -0.007) (-0.042, -0.001)
Outdoor -0.006 -0.014* -0.012*
(-0.029, 0.017) (-0.028, -0.001) (-0.024, 0.000)
Low-frequency Hallway -0.012 -0.025* -0.021 *
power (log 10)d (-0.037, 0.013) (-0.040, -0.009) (-0.034,-0.008)
Indoor, 24-hr 0.001 -0.014 -0.010
(-0.036, 0.038) (-0.036, 0.008) (-0.029, 0.009)
Indoor, 7A.M. -0.001 -0.018 -0.013
(-0.038, 0.036) (-0.040, 0.004) (-0.032, 0.006)
Outdoor -0.008 -0.012 -0.011 *
(-0.029, 0.013) (-0.025, 0.001) (-0.022, 0.000)
SDNN (log 10) Hallway -0.007 -0.004 -0.005*
(-0.016, 0.003) (-0.010, 0.002) (-0.010, 0.000)
Indoor, 24-hr 0.002 -0.007* -0.005
(-0.011, 0.015) (-0.015, 0.000) (-0.012, 0.002)
Indoor, 7A.M. 0.001 -0.008* -0.006
(-0.012, 0.014) (-0.016, -0.001) (-0.013, 0.001)
Outdoor -0.002 -0.004* -0.004*
(-0.010, 0.005) (-0.008, 0.000) (-0.007, 0.000)
SDNN, standard deviation of all normal R-wave to R-wave intervals.
"Adjusted for age and sex.bAdjusted for age, sex, and cardiovascular health status. '0.15-0.40 Hz. dO.04-0.15 Hz. *p <0.05.
test days. The second greatest loss of data
was attributable to exclusion of HRV
records from the analysis if 15% or more of
all possible QRS complexes were QRS arti-
facts and were consequently identified as
artificial QRS complexes. Overall, the pro-
portion of potential subjects' days for
which test results were actually obtained
was 74.4% in analyzing the relationship
between changes of particulate matter lev-
els and the changes in HRV.
As summarized in Table 1, the mean
age ofall participants was 81 years, ranging
from 65 to 89; 19 subjects (73%) were
female, and 25 (96%) were white. On the
basis of medical records and physician's
diagnosis, 18 of the participants were clas-
sified in the compromised group.
Individuals with previous cardiovascular
conditions (compromised group) were
older; the average age was 82 years as com-
pared to 78 years for the other eight partic-
ipants. Most of the compromised partici-
pants (61%) had a history ofhypertension.
Also presented in Table 1 are the mean
levels of HRV indices in the study popula-
tion. These values are the means of the
average test results for each individual, aver-
aged over the 3-week study period. Mean
values are presented for the entire study
population and separately for persons with
and without compromised cardiovascular
heath status. In nearly all cases, test results
for persons without compromised health
status were more favorable than results for
those in the compromised group.
Air monitoring results are presented by
Creason et al. (17). In summary, the means
± standard deviations (range) ofPM2.5 from
the study site monitors were 17.6 ± 6.9
(9.0-30), 9.8 ± 3.7 (5.2-17.4), and 16.1 ±
6.9 (8.0-32.2) pg/im3 for hallway, indoor-7
A.M., and outdoor monitors, respectively.
Following the convention in the HRV
literature, all HRV indices were trans-
formed with logarithms. The primary
hypothesis in this study was that with an
increase in PM2.5 levels there would be a
trend of decrease in HRV indices. Because
the study only lasted 3 weeks and because
the daily variations of the exposure and the
HRV indices were measured concurrently,
the observed association between the con-
centration ofair pollutants and the levels of
HRV indices was reflective of the acute
effects of air pollutants on cardiac auto-
nomic control beyond the lifetime accumu-
lation ofall other exposures that may have a
chronic effect on HRV. Tests for autocorre-
lation were performed for all models, and
none were statistically significant at the p <
0.10 level. Thus, an unrestricted correlation
matrix was assumed for all models. From
the mixed models, the age and sex-adjusted
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but a slope for each subject was not. Two
covariance structures were considered for the
repeated measures ofthese longitudinal data.
One assumed a simple model ofno correla-
tion of residuals across time. The other
assumed an error covariance matrix allowing
for dedining correlation of residuals based
on distance (time in days) between measure-
ments. In this structure, if readings were 1
day apart the correlation was r, and for > 1
day apart the correlation was r to the power
of the number of intervening days. Two
final models, one fitting individual PM2.5
slopes for each of the health status groups
and one fitting only an overall slope, are pre-
sented here. The final form for each model
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P-coefficients and their 95% confidence
interval (CI) by baseline cardiovascular
health status (compromised status), and
coefficients adjusted for cardiovascular
health status in the combined model, are
presented in Table 2.
In the combined models (termed Beta
Overall), the high-frequency (HF) power
component of HRV, the low-frequency
(LF) component, and the time-domain
component [the standard deviation of all
normal R-R intervals (SDNN)] are each
inversely associated with all four PM2*5 mea-
sures. However, conventional statistical sig-
nificance (p < 0.05) is reached for only three
of the four PM2.5 metrics in HRV-HF, for
two of the metrics for HRV-LF, and mar-
ginally with two of the PM2.5 metrics for
SDNN. The largest and statistically signifi-
cant inverse associations were among indi-
viduals with previous cardiovascular-related
conditions (termed Beta Compromised),
whereas none ofthe associations among par-
ticipants without previous cardiovascular-
related conditions (termed Beta Healthy)
were statistically significant.
When each of these analyses was
repeated with a 1-day lag between PM2.5
concentrations and HRV, none ofthe asso-
ciations were significantly different (data
not shown). Because of the lack of a bio-
logically plausible hypothesis to justify fur-
ther investigations oflag functions, no fur-
ther lags were considered.
A categorical analysis was performed to
evaluate the risk of having a low HRV-HF
day on days when PM2 5 concentrations
were at or above 15 fig/m3. A participant
was classified as having a low HRVday ifhis
or her HRV-HF level fell below the first ter-
tile of the individual's HRV-HF distribu-
tion over the entire study period. The level
of PM2*5 > 15 pg/m3 was used to define
high pollution days. On average, a low
HRV-HF day occurred on 44% ofhigh pol-
lution days. In contrast, a low HRV-HF day
occurred on only 20% ofdays when PM 5
concentrations were below 15 ig/min.
Logistic regression models were used to esti-
mate the age and previous cardiovascular
conditions adjusted odds ratio (95% CI)
expressing the relationship between low
HRV-HF and high pollution days; the
resulting adjusted odds ratio of 3.08 (1.43,
6.59) can be interpreted as finding the risk
of having an HRV-HF value in the lowest
tertile ofeach individual's distribution to be
three times greater on days when the PM2.5
concentration was 15 pg/m3 or greater com-
pared with days below this concentration.
Discussion
The data from this study suggest that ele-
vated concentrations ofPM2.5 within an
environmentally relevant range are associat-
ed with lower HRV in the elderly, and that
the association is more pronounced in
elderly individuals with previous cardiovas-
cular-related conditions.
Caution should be exercised when inter-
preting these results. The study participants
were selected from only one retirement cen-
ter in a geographically defined area; thus,
the results may not be representative of
other populations. Also, within the retire-
ment center, we only studied 26 volunteers
who agreed to participate. We did not have
data to compare the eligible individuals
who did not participate with those who did.
Another limitation of this study was that
the measurements ofPM2.5 exposure were
mostly based on a common microenviron-
ment shared by the participants rather than
on personal exposure monitoring. Although
fine PM is highly penetrable and may be
evenly diffused in a defined microenviron-
ment and although the study site is located
in a residential area away from major road-
ways, misclassification of PM exposure at
individual levels cannot be ruled out.
However, a recent study comparing person-
al sampling of PM at the individual levels
with indoor and outdoor ambient PM con-
firmed the usefulness of ambient PM mea-
sured outdoor and indoor to assess personal
PM exposure over time (21). Our data from
five individuals who wore a personal moni-
tor for the entire study period indicated a
high correlation between personal monitor-
ing of PM concentrations and the microen-
vironmental PM concentrations determined
by a stationary monitor. Regardless ofthese
limitations, to our knowledge, this is the
first study to relate day-to-day variations of
PM concentration with cardiac autonomic
control in a susceptible population and thus
demonstrating potential pathophysiologic
mechanisms linking environmentally rele-
vant PM exposure and excessive cardiovas-
cular morbidity and mortality.
On one hand, it has been consistently
demonstrated that exposure to particulate
air pollution is associated with increased
mortality and morbidity, especially cardio-
vascular morbidity and mortality (1-9). On
the other hand, there has been a lack ofbio-
logically demonstrable mechanisms for such
an association, particularly at environmen-
tally relevant PM concentrations. In recent
years, analysis of beat-to-beat HRV has
emerged as a clinically and epidemiological-
ly useful noninvasive method to quantita-
tively assess cardiac autonomic activity
(22-38). As a result of interaction between
sympathetic and parasympathetic activity,
HRV shows periodicity over time. This
periodicity can be identified through spec-
tral analysis as the sum of a series of sine
and cosine functions of varying amplitudes
and frequencies (frequency domain analy-
sis). Previous work (22-30) has shown that
heart rate oscillations at low frequencies
(0.04-0.15 Hz) are under the influence of
both the sympathetic and parasympathetic
nervous systems, whereas oscillations at high
frequencies (0.15-0.40 Hz) are under the
influence of the parasympathetic system
only and have been regarded as a marker of
cardiac parasympathetic activity. Clinically
based studies have consistently demonstrat-
ed that lower HRV values were associated
with higher risk of all-cause mortality
among survivors of myocardial infarction
(31-34). Lower HRV has also been related
to sudden cardiac death (35). Results from
population-based cohort studies suggested
that lower HRV is associated with an
increased risk of developing coronarv heart
disease (36,37). It has been proposed that
HRV be used as a prognostic factor for
myocardial infarction (38). Because of the
richness of HRV literature and its consis-
tently demonstrated association with cardio-
vascular disease, we originally hypothesized
that PM pollution leads to increased cardio-
vascular morbidity and mortality partially
through PM exposure altering the balance of
cardiac autonomic control, thus increasing
the susceptibility to adverse cardiac events.
Our results of an inverse association
between daily levels of PM concentration
and HRV provide a suggestive link between
particulate air pollution and cardiovascular
mortality, especially in the elderly with pre-
existing cardiovascular conditions. The dif-
ference in the magnitude of association by
baseline cardiovascular health status is
indicative ofdifferential susceptibility to PM
exposure. However, this finding needs to be
confirmed by other studies with larger sam-
ple sizes. A somewhat larger HRV effect was
seen in the HF power spectrum than for the
other HRV metrics, suggesting that the
decrease in heart rate variability with higher
concentrations of PM25 may be a conse-
quence of a relatively greater loss of para-
sympathetic control of heart rate. As sum-
marized previously, lower HRV is predictive
of higher risk of cardiovascular disease in
clinically and population-based studies.
However, we cannot find any published lit-
erature demonstrating that day-to-day
change in HRV is associated with day-to-
day change in risk ofcardiovascular disease.
Thus, we consider our study somewhat
exploratory. Our findings do not rule out
the involvement of other potential patho-
physiologic mechanisms. We did not have
data on other potential important cardiovas-
cular responses, such as ventricular ectopy,
ST-wave segment depression, T-wave alter-
nans, and other electrocardiograph changes.
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Although antihypertensive medications
influence cardiac autonomic control, we
consider it less likely that our results were
biased by medication usage because our
daily medication-usage survey did not reveal
any significant day-to-day variations in the
use ofmedications by the study participants
during the study period. Our data did not
show a consistent pattern of association
between PM and HRV in a small group of
relatively healthy individuals. The small
sample size (n = 8) in this group precludes
drawing any firm conclusions about the
absence ofan HRVeffect in this group. Our
data cannot completely rule out the contri-
bution of other co-pollutants, such as car-
bon monoxide (CO) and ozone (03).
However, this is less likely because the study
was conducted during thewinter (minimum
03 exposure) and at a center located away
from major traffic (minimum day-to-day
CO exposure variations).
Whether the magnitude of decline in
HRV seen in our participants has any pre-
dictive value is unknown. However, because
a decline in HRV has been associated with
adverse cardiovascular events, it can be
hypothesized that the lower HRV associated
with increased PM2.5 concentrations
increases the risk for an acute cardiovascular
occurrence in elderly persons with compro-
mised cardiovascular health status via altered
cardiac autonomic control ofheart rate.
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